# MOA Study of Ze 339 in Seasonal Allergic Rhinitis

> **NCT00862225** · PHASE2 · COMPLETED · sponsor: **Max Zeller Soehne AG** · enrollment: 18 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Desloratadin
- **DRUG:** IG-RD-001 / Ze 339

## Key facts

- **NCT ID:** NCT00862225
- **Lead sponsor:** Max Zeller Soehne AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862225, "MOA Study of Ze 339 in Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00862225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*